-VEGF Novel anti-vascular endothelial growth factor antibody and composition for preventing or treating age-related macular degeneration comprising thereof

• 1. 用于预防、诊断或者治疗癌症或血管发生相关疾病的抗VEGF抗体和含有所述抗体的药物组合物 [P] . 中国专利： CN105263961B . 2019.08.27
• 2. 用于预防、诊断或者治疗癌症或血管发生相关疾病的抗VEGF抗体和含有所述抗体的药物组合物 [P] . 中国专利： CN105263961A . 2016-01-20
• 3. -VEGF Novel anti-vascular endothelial growth factor antibody and composition for preventing or treating age-related macular degeneration comprising thereof [P] . 韩国专利： KR101908330B1 . 2018-10-16

  机译： -VEGF新型抗血管内皮生长因子抗体和用于预防或治疗与年龄有关的黄斑变性的组合物

• 4. Vascular endothelial cell growth factor (VEGF) antagonists useful for the treatment of age-related macular degeneration [P] . NZ305699A . 2000-02-28

  机译： 血管内皮细胞生长因子（VEGF）拮抗剂可用于治疗与年龄有关的黄斑变性

• 5. PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGE-RELATED MACULAR DEGENERATION CONTAINING RNA COMPLEX TARGETING CONNECTIVE TISSUE GROWTH FACTOR [P] . 韩国专利： KR20190037166A . 2019-04-05

  机译： 预防或治疗包含RNA复合物的结缔组织生长因子的年龄相关性黄斑变性的药物组合物

• 1. What is the best anti-vascular endothelial growth factor agent for the treatment of diabetic macular edema? Review of the 2-year results of Diabetic Retinopathy Clinical Research Network Protocol T [J] . Michal Schaap-Fogler, Rita Ehrlich 眼科学报（英文版） . 2016,第004期
• 2. Risk Factors for Age-Related Macular Degeneration in Elderly Chinese Population in Shenyang of China [J] . JIA LiHong, SHEN XueLi, FAN Rui, 生物医学与环境科学（英文版） . 2011,第005期
• 3. A novel approach in preventing vascular leakage and angiogenesis in wet age-related macular degeneration [J] . Kaori H.Yamada 中国神经再生研究（英文版） . 2022,第008期
• 4. Recent advances and future directions for the pharmacogenetic basis of anti-VEGF treatment response in neovascular age-related macular degeneration [J] . Moeen Riaz, Paul N. Baird 中国神经再生研究（英文版） . 2017,第004期
• 5. Does Anti-Vascular Endothelial Growth Factor Treatment Delay Photoreceptor Maturation in Preterm Infants? [J] . El?in Süren Ersan ?etinkaya, Mehmet Fatih Kü?ük, Musatafa Kalayc?, 眼科学期刊（英文） . 2020,第001期
• 6. Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761) Reply [J] . Maguire Maureen G. Ophthalmology . 2017,第3期
• 7. Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration. [J] . Rosenfeld PJ, Schwartz SD, Blumenkranz MS, Ophthalmology . 2005,第6期
• 8. Outcomes with Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy for Neovascular Age-Related Macular Degeneration (AMD) and Diabetic Macular Edema (DME) in Routine Clinical Practice [J] . Pitcher John D., Moshfeghi Andrew A., Lucas Genevieve, Investigative ophthalmology & visual science . 2018,第9期
• 9. Sustained Release Anti-VEGF by Microparticles for Treating Wet Age-Related Macular Degeneration [C] . Pengfei Jiane, Matthew P. Ohr, Katelyn E. Swindle-Reilly Society for Biomaterials annual meeting and exposition . 2018
• 10. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015
• 11. MACULAR ATROPHY INCIDENCE IN ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR–TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION [O] . Irmela Mantel, Ali Dirani, Marta Zola, -1
• 12. Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration [O] . Anna V. Zarubina, Orly Gal-Or, Carrie E. Huisingh, 2017

• 1. 玻璃体腔注射抗血管内皮生长因子单克隆抗体治疗视网膜静脉阻塞继发黄斑水肿的21例临床观察 [C] . 陈玮 ,赵晓春 ,郭颖 . 第十三届福州市科协学术年会 . 2015
• 2. 抗VEGF治疗应答不良的晚期湿性年龄相关性黄斑变性的视网膜病变分析 [A] . 李学敏 . 2020